PUBLIC CONTRACT · 2024
4180246/2024-aq. Central T265 - Tenofovir 245 mg comp revest
- Contract value
- €11,340.00
- Signed on
- 21 August 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11288222PUBLISHED SUBJECT
4180246/2024-AQ. CENTRAL T265 - TENOFOVIR 245 MG COMP REVEST
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Teva Pharma - Produtos Farmacêuticos, Lda · Tax ID 507045491
Values and timeline
- Contract price
- €11,340.00
- Procedure base price
- €11,340.00
- Total effective price
- €11,340.00
- Publication date
- 17 March 2025
- Award date
- 9 August 2024
- Signing date
- 21 August 2024
- Performance period
- 132 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 481/2023 - Acordo quadro para fornecimento de medicamentos diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7518313
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.